4//SEC Filing
Schonharting Florian 4
Accession 0001491877-12-000024
CIK 0000827809other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 1:59 PM ET
Size
7.1 KB
Accession
0001491877-12-000024
Insider Transaction Report
Form 4
QLT INC/BCQLTI
NB Public Equity K/S
10% Owner
Transactions
- Purchase
Common Shares, no par value
2012-05-16$6.67/sh+50,000$333,340→ 7,447,626 total
Schonharting Florian
10% Owner
Transactions
- Purchase
Common Shares, no par value
2012-05-16$6.67/sh+50,000$333,340→ 7,447,626 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.60 to $6.70 inclusive. The Reporting Owners undertake to provide to QLT, Inc., any security holder of QLT, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]Reported shares are owned directly by NB Public Equity K/S (the "Fund"), and indirectly by the other listed Reporting Owner.
- [F3]Florian Schonharting is a direct investor in a limited partner in the Fund and a director of Nordic Biotech Advisors ApS, which owns 100% of the shares of NB Public Equity Komplementar ApS, the general partner of the Fund. Mr. Schonharting disclaims beneficial ownership in the securities, except to the extent of his pecuniary interest therein.
Documents
Issuer
QLT INC/BC
CIK 0000827809
Entity typeother
Related Parties
1- filerCIK 0001360509
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 1:59 PM ET
- Size
- 7.1 KB